Acumen Pharmaceuticals, Inc.ABOSNASDAQ
LOADING
|||
Cash Flow Performance
Trending lower, below historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-83.54%
↓ 279% below average
Average (5y)
-22.04%
Historical baseline
Range
High:-1.18%
Low:-83.54%
CAGR
+134.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -83.54% | -261.0% |
| 2023 | -23.14% | -43.7% |
| 2022 | -16.11% | -131.5% |
| 2021 | -6.96% | -437.9% |
| 2020 | -1.29% | -9.3% |
| 2019 | -1.18% | - |